MYD88 and neoplasm: This was in part dependent on HMGB1, because no upregulation of the activation markers was observed when using DCs of MyD88 KO mice (Figures 4a1 and b1) or when incubating the tumor cell SNs with anti-HMGB1 antibody, respectively (Supplementary Figure 2).